Intrommune Therapeutics

Intrommune Therapeutics, Inc. is a biotechnology company located in New York, NY. Intrommune is developing food allergy immunotherapies that are delivered while you brush your teeth, a lifelong habit that is ingrained in most people and ensures daily use of our product. Intrommunes elegant new treatment platform for food allergies is expected to be safe, effective and convenient. Intrommunes first product is a therapy for patients who suffer from peanut allergy. Intrommune is developing the oral mucosal immunotherapy (OMIT) platform for food allergies. It is a long-term solution for the 220 million, including 32 million people in the U.S., who...

Intrommune therapeutics operates in the Biotechnology research industry.

Intrommune therapeutics's revenue is 11m - 100m

Intrommune therapeutics has 11 - 50 employees.